Detalles de la búsqueda
1.
Paclitaxel liposome (Lipusu) based chemotherapy combined with immunotherapy for advanced non-small cell lung cancer: a multicenter, retrospective real-world study.
BMC Cancer;
24(1): 107, 2024 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38238648
2.
Metabolic landscape dysregulation in bronchoalveolar lavage fluid of checkpoint inhibitor pneumonitis.
Clin Immunol;
247: 109230, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36646189
3.
Impact of crizotinib on long-term survival of ALK-positive advanced non-small-cell lung cancer: A Chinese multicenter cohort study.
Chin J Cancer Res;
31(3): 481-488, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31354217
4.
Corrigendum to "Metabolic landscape dysregulation in bronchoalveolar lavage fluid of checkpoint inhibitor pneumonitis" [Clinical Immunology 247 (2023) 109230].
Clin Immunol;
249: 109261, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36863991
5.
PI3K in cancer: its structure, activation modes and role in shaping tumor microenvironment.
Future Oncol;
14(7): 665-674, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29219001
6.
Hippo pathway in non-small cell lung cancer: mechanisms, potential targets, and biomarkers.
Cancer Gene Ther;
2024 Mar 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38499647
7.
Prognostic Factors and Survival Benefits of Antitumor Treatments for Advanced Non-Small Cell Lung Cancer Patients With Central Nervous System Metastasis With or Without Driver Genes: A Chinese Single-Center Cohort Study.
Front Oncol;
12: 879554, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35558520
8.
A Novel c-Mesenchymal-Epithelial Transition Factor Intergenic Fusion Response to Crizotinib in a Chinese Patient With Lung Adenocarcinoma: A Case Report.
Front Oncol;
11: 727662, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34778041
9.
Prognostic impact of maximum standardized uptake value on 18 F-FDG PET/CT imaging of the primary lung lesion on survival in advanced non-small cell lung cancer: A retrospective study.
Thorac Cancer;
12(6): 845-853, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33512768
10.
Characterization of Somatic Mutations That Affect Neoantigens in Non-Small Cell Lung Cancer.
Front Immunol;
12: 749461, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35356154
11.
MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregulation and Agents Targeting the HGF/c-Met Axis.
Onco Targets Ther;
13: 2491-2510, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32273721
12.
Patterns of response in metastatic NSCLC during PD-1 or PD-L1 inhibitor therapy: Comparison of the RECIST 1.1 and iRECIST criteria.
Thorac Cancer;
11(4): 1068-1075, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32129934
13.
Clinicopathological characteristics of lung cancer in patients with systemic sclerosis.
Clin Respir J;
14(12): 1131-1136, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32770829
14.
[Clinical-radiological-pathological Characteristics of 297 Cases of Surgical Pathology Confirmed Benign Pulmonary Lesions in Which Malignancy Could Not Be Excluded in Preoperative Assessment: A Retrospective Cohort Analysis in a Single Chinese Hospital].
Zhongguo Fei Ai Za Zhi;
23(9): 792-799, 2020 Sep 20.
Artículo
en Zh
| MEDLINE | ID: mdl-32773007
15.
Prospect of immunotherapy combined with anti-angiogenic agents in patients with advanced non-small cell lung cancer.
Cancer Manag Res;
11: 7707-7719, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31616186
16.
Elevated levels of pre-treatment lactate dehydrogenase are an unfavorable predictor factor in patients with EML4-ALK rearrangement non-small cell lung cancer treated with crizotinib.
Cancer Manag Res;
11: 8191-8200, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31564978
17.
Efficacy of Crizotinib for Advanced ALK-Rearranged Non-Small-Cell Lung Cancer Patients with Brain Metastasis: A Multicenter, Retrospective Study in China.
Target Oncol;
14(3): 325-333, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31025247
18.
Clinical features and outcomes of ALK rearranged non-small cell lung cancer with primary resistance to crizotinib.
Thorac Cancer;
10(5): 1213-1219, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30993895
19.
Real-world data on EGFR/ALK gene status and first-line targeted therapy rate in newly diagnosed advanced non-small cell lung cancer patients in Northern China: A prospective observational study.
Thorac Cancer;
10(7): 1521-1532, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31144459
20.
Immunotherapy combined with epidermal growth factor receptor-tyrosine kinase inhibitors in non-small-cell lung cancer treatment.
Onco Targets Ther;
11: 6189-6196, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30288054